Codes / ICD10CM / M10.18

M10.18 Lead-induced gout, vertebrae

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Lead-induced gout, vertebrae
  • Technical Term: Lead-induced gout, vertebrae

Summary

Lead-induced gout, vertebrae is a form of arthritis affecting the vertebrae, caused by the deposition of urate crystals due to lead exposure. Lead interferes with uric acid metabolism, leading to elevated uric acid levels and crystal formation in the spinal joints. This results in sudden, severe inflammation and pain in the vertebrae.

Causes

Lead-induced gout, vertebrae occurs when lead exposure disrupts uric acid excretion by the kidneys. This disruption causes uric acid to accumulate in the blood, leading to crystal deposition in the vertebrae. Lead sources may include occupational exposure, contaminated water, or old paint.

Risk Factors

  • Occupational lead exposure (e.g., mining, battery manufacturing)
  • Environmental lead contamination (e.g., old plumbing, polluted soil)
  • Chronic lead ingestion (e.g., from lead-based paint or contaminated water)
  • Preexisting kidney dysfunction
  • High dietary purine intake
  • Male gender
  • Alcohol consumption

Symptoms

  • Sudden, intense back pain
  • Swelling, redness, and warmth in the affected vertebrae
  • Tenderness to touch
  • Limited range of motion in the spine
  • Possible kidney stone formation (due to lead-induced renal effects)

Diagnosis

Diagnosis involves a physical examination of the spine, assessment of symptoms, and laboratory tests to measure blood uric acid levels and lead levels. Imaging studies, such as X-rays or MRI, may be used to evaluate joint damage or crystal deposition in the vertebrae.

Treatment Options

Treatment focuses on reducing lead exposure, managing uric acid levels, and alleviating symptoms. This may include chelation therapy to remove lead from the body, medications to lower uric acid (e.g., allopurinol), and anti-inflammatory drugs to reduce joint pain and swelling. Lifestyle modifications, such as avoiding purine-rich foods and alcohol, may also be recommended.

Prognosis and Follow-Up

With appropriate treatment, symptoms can be managed, and further crystal deposition may be prevented. Long-term follow-up is important to monitor kidney function, uric acid levels, and lead exposure. Untreated or poorly managed cases may lead to chronic joint damage or renal complications.

Complications

  • Chronic back pain or spinal stiffness
  • Permanent joint damage in the vertebrae
  • Kidney dysfunction or failure
  • Increased risk of kidney stones
  • Recurrent gout attacks

Lifestyle & Prevention

  • Avoid lead exposure by using safe water sources and avoiding old paint or contaminated environments.
  • Limit intake of purine-rich foods (e.g., red meat, seafood) and alcohol.
  • Maintain a healthy weight and stay hydrated.
  • Follow occupational safety guidelines if working with lead.

When to Seek Professional Help

Seek medical attention if you experience sudden, severe back pain, swelling, or stiffness, especially if you have a history of lead exposure. Prompt evaluation is important to prevent complications and initiate treatment.

Tips for Medical Coders

Document the specific site (vertebrae) and confirm lead exposure as the cause. Ensure clinical documentation supports the diagnosis and aligns with the code's specificity. Verify that no other site is indicated, as this code is limited to vertebrae involvement.

Book a walkthrough

M10.18 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.